We provide a comprehensive platform for in vivo and in vitro tumor modeling to support oncology drug discovery and translational research. Our services include subcutaneous and orthotopic xenografts, peritoneal metastasis models, and tumor cell line screening across multiple cancer types. These models are essential for evaluating drug efficacy, resistance mechanisms, and tumor microenvironment modulation, enabling development of targeted therapies, immune checkpoint inhibitors, and ADCs.
List of Diseases and Research Models
-
Disease Type
Cell Line
-
Acute Leukemia
•Nalm6-Luc
•WEHI-3 (Rat/Mouse) -
Colonic Adenocarcinoma Model
•CT-26 (Rat/Mouse)
-
Osteosarcoma
•Saos-2-Luc
-
Lung Squamous Cell Carcinoma
•NCI-H226-Luc
-
Lymphoma
•Raji-Luc
•Jurkat-Luc -
Promyeloid Leukemia
•HL-60-Luc
-
Plasma Cell Leukemia
•NCI-H929-Luc
-
Gastric Cancer
•MGC80-3-Luc
•HGC-27
•AGS
•MGC803 -
Pancreatic Cancer
•BxPC-3
-
Chronic Myeloid Leukemia
•K562
-
Skin Cancer
•SCL-1
•A431
•COLO-16 -
Lung Cancer
•A549
-
Melanoma
•A375.S2
-
Liver Cancer
•HepG2
•MHCC-97H
•Huh-7 -
Cervical Cancer
•Hela
•CaSki -
Orthotopic Lung Cancer Model
•LL/2 cell (Rat/Mouse)